President - Diag & Spatial Bi

Director

Chief Executive Officer

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Institution	Shares	Value	Change
BlackRock, Inc.	12,264,513	$641M	INCREASED
VANGUARD CAPITAL MANAGEMENT LLC	10,179,709	$532M	NEW
MORGAN STANLEY	8,532,873	$446M	INCREASED
FMR LLC	7,899,928	$413M	INCREASED
VANGUARD PORTFOLIO MANAGEMENT LLC	6,480,337	$339M	NEW

Insider	Type	Shares	Value	Date
Steven C. Crouse (President - Diag & Spatial Bi)	SELL	216	$11K	2026-06-02
Steven C. Crouse (President - Diag & Spatial Bi)	EXERCISE	600		2026-06-02
Amy E. Herr (Director)	EXERCISE	6,636	$316K	2026-05-08
Amy E. Herr (Director)	SELL	6,636	$320K	2026-05-08
Kim Kelderman (Chief Executive Officer)	SELL	23,951	$1M	2026-05-05

Bio-Techne Corp. (TECH) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades

Recent Congressional Trades